Work

Novel Human-Derived RET Fusion NSCLC Cell Lines Have Heterogeneous Responses to RET Inhibitors and Differential Regulation of Downstream Signaling

Year: 2021

Type: article

Source: Molecular Pharmacology

DOI: 10.1124/molpharm.120.000207

Authors: Laura Schubert, Anh T. Le, Adriana Estrada-Bernal, Andrea E. Doak, Minjae Yoo, Sarah E. Ferrara, Andrew Goodspeed, Fumi Kinose, Uwe Rix, Aik-Choon Tan, Robert C. Doebele

Institutions: Moffitt Cancer Center, University of Colorado Cancer Center, University of Colorado Anschutz

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Institutes of Health, Cancer Center, University of Colorado, National Cancer Institute, National Center for Advancing Translational Sciences, Colorado Clinical and Translational Sciences Institute

Awards: G1332742017, G1565180698, G3298087253, G3474153124, Colorado Clinical and Translational Sciences Institute, G5029337574, Determining the role of RET fusion kinases' 5' partner and signaling in response to RET inhibitors, SPORE in Lung Cancer, University of Colorado Cancer Center Support Grant, Training Program in Cancer Biology

OpenAlex ID: W3146069114

FWCI: 1.135

Cites: 57

Cited by: 11

Related to: 10